BRBS Q1 2026 Earnings Positive EPS Amidst Limited Disclosure CB Q1 2026 Earnings Solid EPS Beat Amid Premium Growth and Underwriting Discipline SBEV Q2 2025 Earnings Significant EPS Miss Reflects Ongoing Challenges POET Q1 2026 Earnings EPS Misses Expectations as Revenue Remains Unreported ELTX Q1 2026 Earnings Widerthanexpected loss as clinicalstage biotech advances pipeline RXRX Q1 2026 Earnings EPS Beat Despite No Revenue Stock Slips 32